COIN soars as Coinbase books slot on S&P 500 index

FXStreet
Updated
Mitrade
coverImg
Source: DepositPhotos

  • Coinbase's stock COIN will be included in the S&P 500 next Monday.

  • The exchange will replace Discover Financial Services, which will be deleted from the index.

  • COIN stretched its rally, adding a 10.9% gain in after-hours trading to its 3.9% rise on Monday.


COIN rallied over 10% in after-hours trading following an announcement by the S&P Global that Coinbase will replace Discover Financial Services in the S&P 500 index beginning May 19.


Coinbase stock surges following upcoming launch on the S&P 500 index


Crypto exchange Coinbase will become the first crypto stock in the popular S&P 500. The exchange's stock, COIN, will go live on the index beginning next Monday, according to a press release by the S&P Global Media Center. 


COIN will replace Discover Financial Services, which Capital One Financing Corp recently acquired.


The S&P 500, with a market cap of approximately $47 trillion, is a stock market index that tracks the performance of the 500 largest publicly traded companies in the United States. It serves as a broad representation of US stock and is often used as a benchmark to gauge the overall health of the equity market.


COIN's inclusion in the index would also grant larger financial players indirect access to investing in crypto stocks, potentially boosting crypto legitimacy among traditional investors.


The milestone follows years of legal battles between Coinbase and the Securities and Exchange Commission (SEC). The agency eventually dropped its lawsuit against the exchange in February.


"Imagine battling the SEC for years, only to ascend to the S&P 500 just months later. There's no worthier steward of this victory than Coinbase," said Bitwise Head of Alpha Strategies Jeff Park in a Monday X post.


Coinbase CEO Brian Armstrong highlighted that the milestone signifies "crypto is here to stay."


COIN closed the day with a 3.96% gain, but surged over 10% in after-hours trading following the announcement.


* The content presented above, whether from a third party or not, is considered as general advice only.  This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

goTop
quote
Do you find this article useful?
Related Articles
placeholder
Apple’s Strategic Evolution in Q2 FY25Apple reported Q2 FY25 revenue of $95.4 billion and net income of $24.8 billion, with Services contributing 28% of total sales and 45% of gross profit—showcasing its margin supremacy.
Author  TradingKey
46 mins ago
Apple reported Q2 FY25 revenue of $95.4 billion and net income of $24.8 billion, with Services contributing 28% of total sales and 45% of gross profit—showcasing its margin supremacy.
placeholder
Asian stock rally fades fast along with US dollar after Trump’s trade dealsAsian markets broke down on Tuesday just as fast as they had rallied on Monday. Traders across the region walked away from early gains after fresh fears over president Donald Trump’s trade decisions began creeping in.
Author  Cryptopolitan
1 hour ago
Asian markets broke down on Tuesday just as fast as they had rallied on Monday. Traders across the region walked away from early gains after fresh fears over president Donald Trump’s trade decisions began creeping in.
placeholder
Crude Oil Market Imbalance: Weak Q1 Results from “King of Oil” Aramco May Be Just the BeginningAffected by persistently weak global oil prices, Saudi Aramco’s profits fell by 4.6% year-on-year in Q1, signaling more uncertain growth prospects ahead.
Author  TradingKey
Yesterday 08: 43
Affected by persistently weak global oil prices, Saudi Aramco’s profits fell by 4.6% year-on-year in Q1, signaling more uncertain growth prospects ahead.
placeholder
Trump Announces Major Drug Price Cuts! Pharma Stocks Face Potential Crisis​Trump signals an executive order to slash drug prices, causing a sharp sell-off in Asian pharmaceutical stocks. Major companies like Johnson & Johnson, Pfizer, and Abbott could be hit hard.
Author  TradingKey
Yesterday 07: 10
​Trump signals an executive order to slash drug prices, causing a sharp sell-off in Asian pharmaceutical stocks. Major companies like Johnson & Johnson, Pfizer, and Abbott could be hit hard.
placeholder
US and Asian stock futures climb as US and China reach a trade dealUS stock futures rose Sunday night after Washington and Beijing hinted they want to cool their long-running tariff fight, giving investors fresh hope that the world’s two largest economies can find common ground.
Author  Cryptopolitan
Yesterday 01: 26
US stock futures rose Sunday night after Washington and Beijing hinted they want to cool their long-running tariff fight, giving investors fresh hope that the world’s two largest economies can find common ground.
Real-time Quote